| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 268 | 371 | 707 | 8,620 | | Cost of Revenue | 68 | 161 | 273 | 7,967 | | | Gross Profit | 200 | 210 | 434 | 653 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| 384 | | Selling General and Administrative | 3,878 | 4,526 | 5,603 | 8,292 | | Non Recurring |
-
|
-
| 1,113 | 9,775 | | Others | 273 | 302 | 404 | 629 | | | | Total Operating Expenses |
-
|
-
|
-
| 19,080 | | | | Operating Income or Loss | (3,951) | (4,618) | (6,686) | (18,427) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,482) | 64 | (293) | (323) | | Earnings Before Interest And Taxes | (8,618) | (4,554) | (6,979) | (18,750) | | Interest Expense | 221 | 370 | 408 | 585 | | Income Before Tax | (8,839) | (4,924) | (7,387) | (19,335) | | Income Tax Expense | 3 | 2 | 8 | 2 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,842) | (4,926) | (7,395) | (19,337) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 10,449 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,842) | (4,926) | 3,054 | (19,337) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,842) | ($4,926) | $3,054 | ($19,337) |
|
0.31% Nasdaq 0.00%
Income Statement
